BE900089A - Utilisation de mini-somatostatines en therapeutique. - Google Patents

Utilisation de mini-somatostatines en therapeutique.

Info

Publication number
BE900089A
BE900089A BE1/11055A BE1011055A BE900089A BE 900089 A BE900089 A BE 900089A BE 1/11055 A BE1/11055 A BE 1/11055A BE 1011055 A BE1011055 A BE 1011055A BE 900089 A BE900089 A BE 900089A
Authority
BE
Belgium
Prior art keywords
mini
somatostatins
therapeutics
somatostatin
parenterally
Prior art date
Application number
BE1/11055A
Other languages
English (en)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE900089A publication Critical patent/BE900089A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/31Somatostatins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'utilisation des mini-somatostatines pour le traitement de la démence sénille évolutive. Les mini-somatostatines de formule I - V sont administrées simultanément avec du glucose, par voie parentérale.
BE1/11055A 1983-07-08 1984-07-05 Utilisation de mini-somatostatines en therapeutique. BE900089A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838318552A GB8318552D0 (en) 1983-07-08 1983-07-08 Organic compounds

Publications (1)

Publication Number Publication Date
BE900089A true BE900089A (fr) 1985-01-07

Family

ID=10545445

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/11055A BE900089A (fr) 1983-07-08 1984-07-05 Utilisation de mini-somatostatines en therapeutique.

Country Status (7)

Country Link
JP (1) JPS6036421A (fr)
AU (1) AU574081B2 (fr)
BE (1) BE900089A (fr)
DE (1) DE3424279A1 (fr)
GB (1) GB8318552D0 (fr)
IT (1) IT1191252B (fr)
PH (1) PH24676A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997011962A1 (fr) * 1995-09-29 1997-04-03 Biomeasure, Incorporated Analogues peptides cycliques de somatostatine

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432324A1 (de) * 1984-09-03 1986-03-13 Henkel KGaA, 4000 Düsseldorf Verfahren zur regelung des disalzgehalts in (alpha)-sulfofettsaeureester-tensiden
US5089472A (en) * 1988-01-26 1992-02-18 Laboratorios Serono S.A. Use of growth hormone releasing factor for improving mental function
PL1787658T3 (pl) 2005-11-10 2012-08-31 Italfarmaco Spa Formulacje o przedłużonym uwalnianiu analogów somatostatyny będących inhibitorami hormonu wzrostu

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328214A (en) * 1979-07-04 1982-05-04 Ciba-Geigy Corporation Cyclopeptides and pharmaceutical preparations thereof and also processes for their manufacture

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997011962A1 (fr) * 1995-09-29 1997-04-03 Biomeasure, Incorporated Analogues peptides cycliques de somatostatine
US5708135A (en) * 1995-09-29 1998-01-13 Biomeasure Incorporated Cyclic peptide analogs of somatostatin
US6001801A (en) * 1995-09-29 1999-12-14 Biomeasure, Inc. Cyclic peptide analogs of somatostatin

Also Published As

Publication number Publication date
AU574081B2 (en) 1988-06-30
JPS6036421A (ja) 1985-02-25
IT1191252B (it) 1988-02-24
IT8448508A0 (it) 1984-07-05
GB8318552D0 (en) 1983-08-10
PH24676A (en) 1990-09-07
AU3036384A (en) 1985-01-10
DE3424279A1 (de) 1985-01-17

Similar Documents

Publication Publication Date Title
DE3875786D1 (de) Schutzbekleidung des typs sicxnyozht erhalten durch behandlung mit plasma.
GR3005447T3 (fr)
DE3679139D1 (de) Behandlung des aktivschlamms im abwasser.
DE69111077T2 (de) Chinazolinderivate um die antitumorwirkung zu verbessern.
ATE38672T1 (de) 7-oxabicycloheptan aminosubstituierte prostaglandinaehnliche verbindungen.
FR2366297A1 (fr) Nouvelles cephalosporines, leur procede de preparation et leur application en therapeutique
ES482097A1 (es) Procedimiento para preparar derivados acilicos de carnitina.
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
PT84257A (fr) Structure q'on peut doubler pour des petits chariots chaise d'enfants
BE900089A (fr) Utilisation de mini-somatostatines en therapeutique.
MC1440A1 (fr) Derives de la pyrrolidine,sa preparation et ses utilisations therapeutiques pour le traitement de l'insuffisance cerebrale
FI922428A0 (fi) Nya 2-amino-5-cyan-1,4- dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
FR2584074B1 (fr) 5,6-epoxy-7-oxabicycloheptane ethers utiles dans le traitement des thromboses
OA05587A (fr) Pulvérisateur portatif, notamment pour le traitement des cultures.
DE69112573D1 (de) Immunstimulierendes arzneimittel, das polare glycopeptidolipide von mycobakterium-chelonae enthält.
DE3886371D1 (de) Herstellung des hblv-virus in der hsb-2 zell-linie.
IT8420213A0 (it) Procedimento per la preparazione di 1,8-diidrossi-10-acil-9-antroni, in particolare per l'uso nel trattamento di psoriasi.
FR2658419B1 (fr) Medicament pour le traitement de la dermatite.
FR2656528B1 (fr) Formule combinee de cimetidine-pirenzepine pour le traitement des ulceres simples de l'estomac et des erosions et procede de traitement.
IT8025176A0 (it) L'impiego in elettroprecipitatori. struttura di elettrodo per
BG97851A (en) Hard dosed forms of almocalante and method for obtaining them
MA19793A1 (fr) Procede de preparation de 1 - ( 1,3 - dioxolanne -2-yl "methyl) -1 h - imidazoles et -1h-1,2,4- triazoles utilisables en therapeutique .
FR2657005B1 (fr) Systeme d'enclouage pour le traitement des fractures notamment du type cervico-trochanteriennes et pertrochanteriennes.
NZ334634A (en) Use of a protein extracted from mammalian liver for treating HIV
FR2662075B1 (fr) Orthese pour le traitement de la racine du pouce, notamment de la rhizarthrose.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SANDOZ S.A.

Effective date: 19940731